Billionaire Profile
Rudolf Maag
Global Rank
#634

Image: Unknown authorUnknown author | Public domain | via Wikimedia Commons

Rudolf Maag

CEO, Medical devices
SWITZERLAND
Real-Time Net Worth
$6.446B
Estimated based on Medical devices stock value as of March 6, 2026
-2.21% (24h)
Age
80
Source
Medical devices
Industry
Healthcare
Citizenship
SWITZERLAND

Biography

Rudolf Maag is a Swiss billionaire recognized for his success in the medical device industry and strategic investments. Born in 1946, Maag built his fortune through ventures like Maag Technologies, DigiInvest, and CleanTech Innovations. His career includes leadership roles at Sandoz AG, Straumann, and Synthes, where he spearheaded significant mergers and acquisitions. With an estimated net worth of $2.5 billion, as of December 2025, Maag is also known for his philanthropic efforts focused on education and environmental sustainability.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Rudolf Maag was born in Liestal, Switzerland, in 1946. He is the son of a butcher. He initially trained as a butcher but had to change careers due to an accident. He attended Handelsschule in Basel and later earned an MBA from INSEAD in 1973.

Rise to Success

Maag's professional journey began at the Basel Trading Company (UTC), where he worked for three years in Ghana. He then joined Sandoz AG in 1973, holding various leadership positions in the agro division, including roles in planning, business development, and marketing. In 1986, he became a director at Institut Straumann AG. Three years later, Maag acquired the medical devices division of Straumann, founding Stratec Medical in 1990. He took the company public in 1996. In 1999, he orchestrated the merger of Stratec with Synthes, a Swiss medical device powerhouse, and built up a 15% stake, which was later sold to Johnson & Johnson.

Key Business Strategies

Maag's success stems from his strategic acquisitions and investments in the medical technology sector. His leadership in merging Stratec with Synthes, and subsequently, the sale to Johnson & Johnson, highlights his ability to identify and capitalize on market opportunities. He also diversified his portfolio through stakes in construction, pharmaceuticals, and hotels.

Philanthropy

Maag is actively involved in philanthropy, with a focus on education and environmental sustainability. He made a significant contribution of $5.9 million to INSEAD in 2005, becoming the institution's largest donor.

Career Milestones

1973

MBA from INSEAD

Graduated with an MBA from INSEAD, a pivotal step in his career.

1990

Founded Stratec Medical

Acquired Straumann's medical device division and founded Stratec Medical.

1999

Merged Stratec with Synthes

Orchestrated the merger of Stratec with Synthes, a Swiss medical device powerhouse, which yielded a 15% stake in the company.

Philanthropy & Social Impact

Education

INSEAD Donation

$5.9M

Made a significant donation to INSEAD in 2005, the largest in the institution's history.